Hologic (HOLX) Current Deferred Revenue (2016 - 2025)
Historic Current Deferred Revenue for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $170.9 million.
- Hologic's Current Deferred Revenue fell 885.33% to $170.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $170.9 million, marking a year-over-year decrease of 885.33%. This contributed to the annual value of $199.7 million for FY2025, which is 620.01% down from last year.
- As of Q4 2025, Hologic's Current Deferred Revenue stood at $170.9 million, which was down 885.33% from $199.7 million recorded in Q3 2025.
- Over the past 5 years, Hologic's Current Deferred Revenue peaked at $232.9 million during Q3 2023, and registered a low of $170.9 million during Q4 2025.
- Over the past 5 years, Hologic's median Current Deferred Revenue value was $199.6 million (recorded in 2022), while the average stood at $203.1 million.
- In the last 5 years, Hologic's Current Deferred Revenue soared by 2170.19% in 2021 and then tumbled by 976.14% in 2024.
- Over the past 5 years, Hologic's Current Deferred Revenue (Quarter) stood at $192.1 million in 2021, then decreased by 0.26% to $191.6 million in 2022, then fell by 0.52% to $190.6 million in 2023, then dropped by 1.63% to $187.5 million in 2024, then decreased by 8.85% to $170.9 million in 2025.
- Its Current Deferred Revenue was $170.9 million in Q4 2025, compared to $199.7 million in Q3 2025 and $212.7 million in Q2 2025.